TY - JOUR
T1 - Predicting Obstructive Sleep Apnea in Patients with Insomnia
T2 - A Comparative Study with Four Screening Instruments
AU - Duarte, Ricardo L.M.
AU - Magalhães-da-Silveira, Flavio J.
AU - Oliveira-e-Sá, Tiago S.
AU - Rabahi, Marcelo F.
AU - Mello, Fernanda C.Q.
AU - Gozal, David
PY - 2019/8
Y1 - 2019/8
N2 -
Purpose: Obstructive sleep apnea (OSA) and insomnia are very prevalent disorders, especially in sleep-lab setting, and insomnia may be the presenting complaint of OSA. Here, we aimed to validate No-Apnea as screening tool for OSA in patients with self-reported insomnia complaints and to compare its performance with other models. Methods: This cross-sectional study involved evaluation of No-Apnea as well as STOP-Bang, NoSAS and Epworth Sleepiness Scale (ESS) in subjects with insomnia being evaluated with full in-lab polysomnography. Discrimination was assessed by area under the curve (AUC), while predictive parameters were calculated by contingency tables. OSA severity was classified based on the apnea/hypopnea index: ≥ 5.0/h as any OSA (OSA
≥5
), ≥ 15.0/h as moderate/severe OSA (OSA
≥15
), and ≥ 30.0/h as severe OSA (OSA
≥30
). Results: Overall, 2591 patients with a clinical diagnosis of insomnia were included. Diagnosis of OSA
≥5
, OSA
≥15
, and OSA
≥30
was of 76.3%, 53.1%, and 32.6%, respectively. At all levels of OSA severity, No-Apnea had sensitivity ranging from 84.5 to 94.1% and specificity ranging from 58.2 to 35.1%. For screening of OSA
≥5
, OSA
≥15
, and OSA
≥30
, discriminatory ability (AUC) of No-Apnea was: 0.790 [95% confidence interval (CI) 0.770–0.810], 0.758 (95% CI 0.740–0.777), and 0.753 (95% CI 0.734–0.772), respectively. Based on AUCs, No-Apnea, STOP-Bang, and NoSAS performed similar at all levels of OSA severity. The ESS did not present satisfactory discrimination as OSA screening model. Conclusions: In a large sample of patients with insomnia, No-Apnea, STOP-Bang, and NoSAS, but not ESS, enable satisfactory and similar discrimination at all levels of OSA severity.
AB -
Purpose: Obstructive sleep apnea (OSA) and insomnia are very prevalent disorders, especially in sleep-lab setting, and insomnia may be the presenting complaint of OSA. Here, we aimed to validate No-Apnea as screening tool for OSA in patients with self-reported insomnia complaints and to compare its performance with other models. Methods: This cross-sectional study involved evaluation of No-Apnea as well as STOP-Bang, NoSAS and Epworth Sleepiness Scale (ESS) in subjects with insomnia being evaluated with full in-lab polysomnography. Discrimination was assessed by area under the curve (AUC), while predictive parameters were calculated by contingency tables. OSA severity was classified based on the apnea/hypopnea index: ≥ 5.0/h as any OSA (OSA
≥5
), ≥ 15.0/h as moderate/severe OSA (OSA
≥15
), and ≥ 30.0/h as severe OSA (OSA
≥30
). Results: Overall, 2591 patients with a clinical diagnosis of insomnia were included. Diagnosis of OSA
≥5
, OSA
≥15
, and OSA
≥30
was of 76.3%, 53.1%, and 32.6%, respectively. At all levels of OSA severity, No-Apnea had sensitivity ranging from 84.5 to 94.1% and specificity ranging from 58.2 to 35.1%. For screening of OSA
≥5
, OSA
≥15
, and OSA
≥30
, discriminatory ability (AUC) of No-Apnea was: 0.790 [95% confidence interval (CI) 0.770–0.810], 0.758 (95% CI 0.740–0.777), and 0.753 (95% CI 0.734–0.772), respectively. Based on AUCs, No-Apnea, STOP-Bang, and NoSAS performed similar at all levels of OSA severity. The ESS did not present satisfactory discrimination as OSA screening model. Conclusions: In a large sample of patients with insomnia, No-Apnea, STOP-Bang, and NoSAS, but not ESS, enable satisfactory and similar discrimination at all levels of OSA severity.
KW - Diagnosis
KW - Insomnia
KW - Obstructive sleep apnea
KW - Polysomnography
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85065592509&partnerID=8YFLogxK
U2 - 10.1007/s00408-019-00232-5
DO - 10.1007/s00408-019-00232-5
M3 - Article
C2 - 31076859
AN - SCOPUS:85065592509
VL - 197
SP - 451
EP - 458
JO - Lung
JF - Lung
SN - 0341-2040
IS - 4
ER -